• Radiation Dose to the Fetus for Pregnant Patients Undergoing Multidetector CT Imaging: Monte Carlo Simulations Estimating Fetal Dose for a Range of Gestational Age and Patient Size

    Radiology: Volume 249: Number 1—October 2008

    Erin Angel, MS Clinton V.Wellnitz, MD Mitchell M. Goodsitt, PhD Nazanin Yaghmai, MD John J. DeMarco, PhD Christopher H.Cagnon, PhD James W. Sayre, DrPH Dianna D.Cody, PhD Donna M.Stevens, MS Andrew N.Primak, PhD CynthiaH. McCollough, PhD Michael F.McNitt-Gray, PhD

    Purpose: To use Monte Carlo simulations of a current-technology multidetector computed tomographic (CT) scanner to in­vestigate fetal radiation dose resulting from an abdominal and pelvic examination for a range of actual patient anato­mies that include variation in gestational age and maternal size.


    Materials and Methods: Institutional review board approval was obtained for this HIPAA-compliant retrospective study. Twenty-four mod­els of maternal and fetal anatomy were created from image data from pregnant patients who had previously under­gone clinically indicated CT examination. Gestational age ranged from less than 5 weeks to 36 weeks. Simulated helical scans of the abdominal and pelvic region were performed, and a normalized dose (in milligrays per 100 mAs) was calculated for each fetus. Stepwise multiple linear regression was performed to analyze the correlation of dose with gestational age and anatomic measurements of maternal size and fetal location. Results were compared with several existing fetal dose estimation methods.


    Results: Normalized fetal dose estimates from the Monte Carlo simulations ranged from 7.3 to 14.3 mGy/100 mAs, with an average of 10.8 mGy/100 mAs. Previous methods yielded values of 10-14 mGy/100 mAs. The correlation between gestational age and fetal dose was not signifi­cant (P = .543). Normalized fetal dose decreased lin­early with increasing patient perimeter (R2 = 0.681, P < .001), and a two-factor model with patient perimeter and fetal depth demonstrated a strong correlation with fetal dose (R2 = 0.799, P < .002).


    Conclusion: A method for the estimation of fetal dose from models of actual patient anatomy that represented a range of gesta­tional age and patient size was developed. Fetal dose cor­related with maternal perimeter and varied more than previously recognized. This correlation improves when maternal size and fetal depth are combined.